May 29, 2022 05:34 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India slams Islamic nations' organisation for 'unacceptable' comments on Yasin Malik case | Buttler batters RCB for RR's smooth sailing into IPL final | Fire reported at Ather Energy's dealership in Chennai, no one injured | Body of Kashmir man to be exhumed 6 months after controversial encounter, orders court | Accused of molesting granddaughter, ex-Uttarakhand minister kills self
Laurus Labs signs agreement with MPP for manufacturing Molnupiravir Molnupiravir

Laurus Labs signs agreement with MPP for manufacturing Molnupiravir

India Blooms News Service | @indiablooms | 21 Jan 2022, 09:42 pm

Mumbai/UNI: Hyderabad-based Laurus Labs Limited on Friday said that it has signed an agreement with MPP (Medicine Patent Pool) for the manufacturing of the oral COVID-19 antiviral medication Molnupiravir.

Commenting on the development, Dr Satyanarayana Chava, Founder and CEO, Laurus Labs said, "We are happy to sign an agreement to manufacture the oral Covid-19 antirviral medication, which is an urgent need of the hour, this is one of the most critical step towards fighting the pandemic and we are happy to contribute to the mission."

Related Images
FOHMA addresses press conference 01 Jan 1970, 05:30 am
Related Videos
PM Modi on Union Budget 2022-2023 01 Feb 2022, 06:28 pm
IBNS Live Business Chat 30 Dec 2021, 05:53 pm